Secretory expression of p53(N15)-Ant following lentivirus-mediated gene transfer induces cell death in human cancer cells

Cancer Investigation
Yue-ping LiGuangxiao Yang

Abstract

p53 (N15)-Ant 32-peptide has been considered a novel and effective peptide for cancer therapy. To further enhance its anticancer effect and overcome the limitation of peptide therapy, a recombinant lentivirus was constructed in this study with the following strategies: the secretory expression of therapeutic peptide and lentivirus gene transfer system. The results demonstrated that LV-NT4(Si)-p53 (N15)-Ant could significantly suppress cell growth and induce rapid cell death in MCF-7 (overexpressed wild-type p53), HepG2 (wide-type p53), OVCAR-3 (mutant type p53) and H1299 (null p53) cells in time-dependent manners through successful gene transfer and secretory expression of therapeutic peptide at 48 h post-infection. Transmission electron microscopy and flow cytometric analysis revealed that LV-NT4(Si)-p53 (N15)-Ant could induce two different kinds of cell death (necrosis and apoptosis) by two different mechanisms, since p53 (N15)-Ant peptide has the potential of blocking interaction of mdm-2 with other protein target, and on the other hand, it could form S-shape helix-loop-helix structures, which is able to rapidly disrupt cancer cell membranes. Based on these finding, LV-NT4 (Si)-p53 (N15)-Ant may be a novel recombinant virus ...Continue Reading

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·N Y IpS P Squinto
May 15, 1997·Nature·Y HauptM Oren
May 15, 1997·Nature·M H KubbutatK H Vousden
Nov 5, 1997·Nature Biotechnology·R ZuffereyD Trono
Oct 10, 1998·Journal of Virology·T DullL Naldini
Mar 18, 2000·The Journal of Biological Chemistry·S FangA M Weissman
Sep 12, 2000·Nature Cell Biology·S D BoydT Jacks
Oct 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·M KanovskyM R Pincus
Dec 19, 2001·British Journal of Cancer·E Bálint E, K H Vousden
Mar 26, 2003·Biochemical Society Transactions·S Laín
Apr 2, 2003·Neuroscience Letters·Desmond J SmithXin Liu
May 22, 2004·Journal of Biomedical Science·Andrew M L LeverJing Zhao

❮ Previous
Next ❯

Citations

Nov 21, 2013·International Journal of Molecular Medicine·Lijun SunXuexin Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis